Enzo Biochem appoints Jon Couchman to Board of Directors and three committees

ENZO BIOCHEM INC

Jon Couchman appointed to Enzo Biochem Board effective November 22, 2024, and to Audit, Compensation, and Nominating/Governance Committees.
Couchman is Managing Member of Couchman Management LLC, holds CFA; previously Chairman/CEO/CFO of Xstelos, Myrexis, Affymax.
Compensation follows standard non-employee director plan as described in the 2023 proxy statement.
No arrangements or understandings with any other person regarding selection; no reportable related-party transactions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jon Couchman

director

ENZO BIOCHEM INC

Effective: 2024-11-22
Filed: November 25, 2024, 6:59 PM ET

On November 22, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Jon Couchman to the Board and to the Board’s Audit Committee, Compensation Committee and Nominating/Governance Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jon Couchman was appointed as director at ENZO BIOCHEM INC.

Action: appointed
Role: director

Exact text from the filing

On November 22, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Jon Couchman to the Board and to the Board’s Audit Committee, Compensation Committee and Nominating/Governance Committee.

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-24-102169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.